HDFC Mutual Fund - HDFC Pharma And Healthcare Fund
Institution · data to Jun 2026
Disclosed value
₹4,846 Cr
Jun 2026 closes
At current prices
…
Current holdings
3
Tracked since
Sep 2024
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Fortis Healthcare Ltd | 6.54% | 0.58 | ₹4,809 Cr |
| Bajaj Healthcare Ltd | 1.69% | flat | ₹20 Cr |
| Laxmi Dental Ltd | 1.37% | flat | ₹17 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, HDFC Mutual Fund - HDFC Pharma And Healthcare Fund — an institution tracked through public shareholding filings — disclosed 3 holdings in Indian listed companies worth ₹4,846 crore. The same holdings-at-filing-value basis put it at ₹1,619 crore in Mar 2026 (+199.3%). Solomo carries these filings back to Sep 2024.
Largest disclosed positions in Jun 2026: Fortis Healthcare Ltd (FORTIS — 6.54% of the company, ₹4,809 crore); Bajaj Healthcare Ltd (BAJAJHCARE — 1.69% of the company, ₹20 crore); Laxmi Dental Ltd (LAXMIDENTL — 1.37% of the company, ₹17 crore).
Changes in the Jun 2026 filings: No longer disclosed after the previous quarter: Torrent Pharmaceuticals Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹4,846 Cr | +199.3% |
| Mar 2026 | ₹1,619 Cr | −71.7% |
| Dec 2025 | ₹5,725 Cr | +303.8% |
| Sep 2025 | ₹1,418 Cr | +2339.6% |
| Jun 2025 | ₹58 Cr | −3.5% |
| Mar 2025 | ₹60 Cr | +83.4% |
| Dec 2024 | ₹33 Cr | +115% |
| Sep 2024 | ₹15 Cr | - |